Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05176262 · ClinicalTrials.gov registry record
A Prospective Study of the Four Food Elimination Diet for Treatment of Eosinophilic Esophagitis
A clinical trial of Eosinophilic Esophagitis, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Active
- Registry status
- 64
- Enrollment target
- 1
- Study location
NCT05176262: Active study of Eosinophilic Esophagitis, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
NCT05176262 is a study of Eosinophilic Esophagitis that is active but no longer recruiting, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 64 participants, below the 863-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05176262, a study of Eosinophilic Esophagitis, is active but no longer recruiting, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is to observe the efficacy of the four food elimination diet.
Primary Outcome
Demonstrate the efficacy of the empiric 4-FED in inducing clinical and histological remission in children with EoE.
Conditions Studied
Study Locations (1)
Illinois
- Ann & Robert H Lurie Children's Hospital of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2011-07 |
| Est. Completion | 2025-12 |
What the registry record for NCT05176262 still lists
NCT05176262 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 863-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Eosinophilic Esophagitis appearing as the primary indexed condition, and to 0 interventions.
NCT05176262 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05176262 about?
NCT05176262 is a clinical study titled "A Prospective Study of the Four Food Elimination Diet for Treatment of Eosinophilic Esophagitis". This study is to observe the efficacy of the four food elimination diet.
What is the current status of trial NCT05176262?
This trial is currently active not recruiting. The enrollment target is 64 participants. The study started on 2011-07. Estimated completion is 2025-12.
What conditions does trial NCT05176262 study?
This clinical trial studies the following conditions: Eosinophilic Esophagitis.
Who is sponsoring clinical trial NCT05176262?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05176262 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eosinophilic Esophagitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05176262's enrollment target sits among peer trials
64 26th of 44 higher than 19 of 44 other Eosinophilic Esophagitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Eosinophilic Esophagitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Characteristics and Inflammatory Markers in Children with Eosinophilic Esophagitis (EoE)
RECRUITING
-
Changes in Esophageal Distensibility With Proton Pump Inhibitors in Patients With Esophageal Eosinophilia: A Pilot Study
RECRUITING
-
Indiana University Gastrointestinal Motility Diagnosis Registry
RECRUITING
-
A Registry for the Food Allergy Community
RECRUITING
-
Patient-Centered Decision Support for Eosinophilic Esophagitis
RECRUITING · NA
-
Eosinophilic Gastrointestinal Disorders Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia